TELA Bio, Inc. (TELA) › Capital ExpendituresTELA Bio, Inc. (TELA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $114.0K2018: $62.0K2019: $197.0K2020: $167.0K2021: $627.0K2022: $872.0K2023: $611.0K2024: $989.0K2025: $448.0K$448.0K2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$448.0K-54.7%2024$989.0K+61.9%2023$611.0K-29.9%2022$872.0K+39.1%2021$627.0K+275.4%2020$167.0K-15.2%2019$197.0K+217.7%2018$62.0K-45.6%2017$114.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share